Detected ·
Estuary Biotherapeutics
$103M—
Estuary Biotherapeutics launches with $103 million in total committed financing to advance targeted gene therapies for ADPKD (autosomal dominant polycystic kidney disease).
- Website
- estuarybio.com
- linkedin.com/company/estuarybio
- Amount
- $103 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-10-16 20:02:40 UTC
- Signal ID
- 765df6d0-2c18-45e8-b703-5386934113e1
As the API returns it
{
"id": "765df6d0-2c18-45e8-b703-5386934113e1",
"created_at": "2026-10-16T20:02:40.112670Z",
"company_name": "Estuary Biotherapeutics",
"company_website_url": "estuarybio.com",
"company_linkedin_url": "https://www.linkedin.com/company/estuarybio",
"event_type": "funding",
"funding_amount": 103000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Estuary Biotherapeutics launches with $103 million in total committed financing to advance targeted gene therapies for ADPKD (autosomal dominant polycystic kidney disease).*"
}